Cargando…
Is a delay in the introduction of human papillomavirus-based cervical screening affordable?
OBJECTIVE: It often takes considerable time for sufficient evidence to accumulate to support implementation of new methods in routine screening. Where national screening programmes are already effective, switching to a more sensitive screening test may not be a priority. Although risk associated wit...
Autores principales: | Castañon, Alejandra, Rebolj, Matejka, Sasieni, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376595/ https://www.ncbi.nlm.nih.gov/pubmed/30280637 http://dx.doi.org/10.1177/0969141318800355 |
Ejemplares similares
-
Recovery strategies following COVID-19 disruption to cervical cancer screening and their impact on excess diagnoses
por: Castanon, Alejandra, et al.
Publicado: (2021) -
COVID-19 disruption to cervical cancer screening in England
por: Castanon, Alejandra, et al.
Publicado: (2022) -
By how much could screening by primary human papillomavirus testing reduce cervical cancer incidence in England?
por: Castanon, Alejandra, et al.
Publicado: (2016) -
Human Papillomavirus Testing in the Last Cervical Screening Round at Age 60–64 Years
por: Schroll, Jeppe Bennekou, et al.
Publicado: (2021) -
Human Papillomavirus Assays and Cytology in Primary Cervical Screening of Women Aged 30 Years and Above
por: Rebolj, Matejka, et al.
Publicado: (2016)